Sulfated polysaccharides have been shown to inhibit human immunodeficiency virus (HIV)
infection in vitro. Dextrin sulfate, fucoidan, and dextran sulfate fail to neutralize virions …

Human immunodeficiency virus type 1 (HIV-1) infection of the brain has been associated
with a severe dementing illness in children and adults. However, HIV-1 antigens are most …

The immunodeficiency virus type 1 is a complex retrovirus. In addition to genes that specify
the proteins of the virus particle and the replicative enzymes common to all retroviruses, HIV …

One to two million people worldwide are infected with the human immunodeficiency virus
type 2 (HIV-2), with highest prevalences in West African countries, but also present in …

Infection by the human immunodeficiency virus (HIV) leads to progressive destruction of the
CD4+ subset of T lymphocytes, resulting in immunodeficiency and AIDS. The selectivity of …

Primary isolates of human immunodeficiency virus type 1 (HIV-1) are much less sensitive to
neutralization by soluble CD4 (sCD4) and sCD4-immunoglobulin (Ig) chimeras (CD4-IgG) …

This report demonstrates that galactosyl ceramide (GalCer) or a molecule derived from it
may serve as an alternative receptor for human immunodeficiency virus in the nervous …

In the central nervous system of AIDS patients, human immunodeficiency virus (HIV) infects
primarily microglia, a cell type of bone marrow origin. Moreover, microglial cells isolated …

Numerous clinical observations and exploitation of cellular and animal models indicate that
glucosylceramide (GlcCer) and galactosylceramide (GalCer) are involved in many …

Human CD4 was expressed on a range of mammalian cell lines. CD4+ non-primate cells,
derived from rat, hamster, mink, cat, and rabbit, bind recombinant gp120 of human …